BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24924835)

  • 1. Diffusion kurtosis imaging study of prostate cancer: preliminary findings.
    Tamura C; Shinmoto H; Soga S; Okamura T; Sato H; Okuaki T; Pang Y; Kosuda S; Kaji T
    J Magn Reson Imaging; 2014 Sep; 40(3):723-9. PubMed ID: 24924835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
    Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.
    Hectors SJ; Semaan S; Song C; Lewis S; Haines GK; Tewari A; Rastinehad AR; Taouli B
    Radiology; 2018 Mar; 286(3):918-928. PubMed ID: 29117481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
    Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J
    Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
    Shinmoto H; Tamura C; Soga S; Shiomi E; Yoshihara N; Kaji T; Mulkern RV
    AJR Am J Roentgenol; 2012 Oct; 199(4):W496-500. PubMed ID: 22997399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution.
    Shinmoto H; Oshio K; Tamura C; Soga S; Okamura T; Yamada K; Kaji T; Mulkern RV
    J Magn Reson Imaging; 2015 Jul; 42(1):56-62. PubMed ID: 25223894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
    Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
    AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
    Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J
    Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why prostate tumour delineation based on apparent diffusion coefficient is challenging: an exploration of the tissue microanatomy.
    Borren A; Moman MR; Groenendaal G; Boeken Kruger AE; van Diest PJ; van der Groep P; van der Heide UA; van Vulpen M; Philippens ME
    Acta Oncol; 2013 Nov; 52(8):1629-36. PubMed ID: 23621751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases.
    Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y
    Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    J Magn Reson Imaging; 2009 Jun; 29(6):1360-6. PubMed ID: 19472393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
    Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
    AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
    Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
    Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
    Tamada T; Prabhu V; Li J; Babb JS; Taneja SS; Rosenkrantz AB
    Radiology; 2017 Jul; 284(1):100-108. PubMed ID: 28394755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.